SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-03-000192
Filing Date
2003-03-27
Accepted
2003-03-27 08:57:31
Documents
3
Period of Report
2003-05-14
Effectiveness Date
2003-03-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE FORM OF NOTICE AND PROXY STATEMENT d12227.htm DEF 14A 156571
3 GRAPHIC logo.jpg GRAPHIC 13084
4 GRAPHIC performance.jpg GRAPHIC 34531
  Complete submission text file 0001206774-03-000192.txt   205961
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 03619396
SIC: 2836 Biological Products, (No Diagnostic Substances)